Dr. Thomas Musci graduated cum laude from Georgetown University School of Medicine in Washington, DC, and then continued his medical training at the University of California, San Francisco, by completing an internship and a residency in obstetrics and gynecology; fellowships in maternal-fetal medicine, cardiovascular research, and medical genetics; and postdoctoral research with Marc Kirschner, PhD, in the department of biochemistry and biophysics. He is board certified in obstetrics and gynecology, maternal-fetal medicine, and medical genetics.
Currently, Dr. Musci serves as Chief Medical Officer at Ariosa Diagnostics, where he has been since 2012. He held past positions in the maternal-fetal medicine program at the California Pacific Medical Center in San Francisco, and as Associate Clinical Professor at the University of California School of Medicine, and as Director of Clinical Affairs, Predictive Health at Novartis Diagnostics, Inc.
He served as the past chair of the Committee on Genetics for the American Congress of Obstetricians and Gynecologists (ACOG), and as a member of the Professional Practice Guidelines Committee for the American College of Medical Genetics (ACMG).
Dr. Musci is on the editorial advisory board of the American Journal of Obstetrics and Gynecology and is an ad hoc peer reviewer of several professional publications, such as the Journal of Maternal-Fetal Medicine, Obstetrics and Gynecology, Placenta, Prenatal Diagnosis, and Journal of Maternal Fetal and Neonatal Medicine.
In addition, he has authored and co-authored many publications on topics including cell-free DNA technology, preeclampsia, fibroblast growth factor, FISH, gene expression, and prenatal screening.